Humeniuk R - Search Results

1

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.

Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. Mishra PJ, et al. Among authors: humeniuk r. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13513-8. doi: 10.1073/pnas.0706217104. Epub 2007 Aug 8. Proc Natl Acad Sci U S A. 2007. PMID: 17686970 Free PMC article.

2

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR. Mishra PJ, et al. Among authors: humeniuk r. PLoS One. 2009 Dec 24;4(12):e8445. doi: 10.1371/journal.pone.0008445. PLoS One. 2009. PMID: 20041160 Free PMC article.

3

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

Humeniuk R, Menon LG, Mishra PJ, Saydam G, Longo-Sorbello GS, Elisseyeff Y, Lewis LD, Aracil M, Jimeno J, Bertino JR, Banerjee D. Humeniuk R, et al. Leukemia. 2007 Dec;21(12):2399-405. doi: 10.1038/sj.leu.2404911. Epub 2007 Aug 23. Leukemia. 2007. PMID: 17713546

4

Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.

Humeniuk R, Mishra PJ, Bertino JR, Banerjee D. Humeniuk R, et al. Mol Cancer Ther. 2009 May;8(5):1045-54. doi: 10.1158/1535-7163.MCT-08-0717. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383845

5

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.

Humeniuk R, Menon LG, Mishra PJ, Gorlick R, Sowers R, Rode W, Pizzorno G, Cheng YC, Kemeny N, Bertino JR, Banerjee D. Humeniuk R, et al. Mol Cancer Ther. 2009 May;8(5):1037-44. doi: 10.1158/1535-7163.MCT-08-0716. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383847

6

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. Mishra PJ, et al. Among authors: humeniuk r. Cancer Res. 2008 Jun 1;68(11):4331-9. doi: 10.1158/0008-5472.CAN-08-0943. Cancer Res. 2008. PMID: 18519693 Free PMC article.

7

Molecular targets for epigenetic therapy of cancer.

Humeniuk R, Mishra PJ, Bertino JR, Banerjee D. Humeniuk R, et al. Curr Pharm Biotechnol. 2009 Feb;10(2):161-5. doi: 10.2174/138920109787315123. Curr Pharm Biotechnol. 2009. PMID: 19199948 Review.

8

The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.

Fares J, Koller R, Humeniuk R, Wolff L, Bies J. Fares J, et al. Among authors: humeniuk r. Blood. 2012 May 24;119(21):5005-15. doi: 10.1182/blood-2011-10-387613. Epub 2012 Mar 28. Blood. 2012. PMID: 22461492 Free PMC article.

9

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.

Morschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, Fegan C, Rule SA, Radford J, Cartron G, Bouabdallah K, Davies AJ, Spurgeon S, Rajakumaraswamy N, Li B, Humeniuk R, Huang X, Bhargava P, Jürgensmeier JM, Salles G. Morschhauser F, et al. Among authors: humeniuk r. Leukemia. 2021 Jul;35(7):2108-2113. doi: 10.1038/s41375-020-01108-x. Epub 2020 Dec 17. Leukemia. 2021. PMID: 33328591 Free PMC article. Clinical Trial. No abstract available.

10

The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate.

Humeniuk R, Rosu-Myles M, Fares J, Koller R, Bies J, Wolff L. Humeniuk R, et al. Blood Cancer J. 2013 Jan;3(1):e99. doi: 10.1038/bcj.2012.44. Epub 2013 Jan 4. Blood Cancer J. 2013. PMID: 23359317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters